Gary Sachs, MD
Enriched profileClinical Vice President and Therapeutic Area Leader, Bipolar Disease and Mood Disorders, Signant Health; Associate Professor of Psychiatry, Harvard Medical School · Massachusetts General Hospital
Gary Sachs is Clinical Vice President and Therapeutic Area Leader, Bipolar Disease and Mood Disorders, Signant Health; Associate Professor of Psychiatry, Harvard Medical School at Massachusetts General Hospital. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Gary Sachs, MD, is Clinical Vice President and Therapeutic Area Leader, Bipolar Disease and Mood Disorders, Signant Health at Massachusetts General Hospital / Harvard Medical School (Founder and Director, Bipolar Clinic and Research Program, MGH; Associate Professor of Psychiatry, Harvard Medical School). The public record shows 92 publications with 5,887 citations (h-index 35), centered on Bipolar Disorder, Depression (MDD). It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies, 3 NIH-funded awards (1998–2006).
- Top research focus: Bipolar Disorder
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
Sponsor: Repligen Corporation
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Sponsor: National Institute of Mental Health (NIMH)
Industry payments
Updated 31 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202528 payments$21,734openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20248 payments
NIH funding
Updated 31 Aug 2026
3 NIH research awards on record, funded 1998–2006 per NIH RePORTER. The latest:
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
Psychopharmacology Bulletin
2025 - Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
Psychopharmacology Bulletin
2025
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gary-sachs-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/gsachs
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
healio.com/authors/gsachs
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Psychiatry residency
University of Maryland/Sheppard Pratt (1982) and Massachusetts General Hospital/McLean Hospital
1986provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thecarlatreport.com ↗ - MD
University of Maryland School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗ - Undergraduate
University of Pennsylvania
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗ - Board Certified
Psychiatry, American Board of Psychiatry & Neurology (ABPN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Scientific Advisory Board, National Alliance on Mental Illness (NAMI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗ - Member
Scientific Advisory Board, Depression and Bipolar Support Alliance (DBSA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
Awards & honors
honors on the public record- Distinguished Fellow
American Psychiatric Association (DFAPA), highest membership honor bestowed by APA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurosciencecme.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Vice President / Therapeutic Area Leader
Bipolar Disease and Mood Disorders, Signant Health (clinical trials technology company; formerly CRF Health/Bracket/Signant)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗ - Founder
Concordant Rater Systems
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Media & interviews
press, podcasts and appearances- "Bipolar Disorder: A 'Patient Centric' Approach to Treatment"
video interview with Dr. Gary Sachs
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - "An Expert Interview With Gary Sachs, MD"
Medscape expert interview series
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.org ↗ - "Bipolar disorder: Interview with Gary Sachs, MD"
Simple and Practical Mental Health podcast/site interview
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →simpleandpractical.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital